Avalo Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of September 2022: 0.01x

Avalo Therapeutics Inc cash flow reinvestment rate. Avalo Therapeutics Inc (AVTX) has a Cash Flow Reinvestment Rate of 0.01x as of September 2022, reinvesting $78.00K (capex $39.00K plus investments $-39.00K) from operating cash flow of $5.73 Million. Explore AVTX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.01x

(Capex + Investments) / Operating CF

Total Reinvested

$78.00K

Capex + Investments

Operating Cash Flow

$5.73 Million

USD

Capital Expenditures

$39.00K

USD

Cash Flow Reinvestment Rate of Avalo Therapeutics Inc (2017–2017)

Cash flow reinvestment rate of Avalo Therapeutics Inc from 2017 to 2017. Historical reinvestment intensity for Avalo Therapeutics Inc across 1 annual periods. Explore AVTX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Avalo Therapeutics Inc Cash Flow Reinvestment Rate by Year (2017–2017)

Avalo Therapeutics Inc cash flow reinvestment rate by year from 2017 to 2017. Year-by-year capital reinvestment analysis for Avalo Therapeutics Inc. For the full cash flow conversion analysis, see Avalo Therapeutics Inc cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2017	1.03x	$12.86 Million	$12.52 Million	$23.32K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow